SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-054561
Filing Date
2018-10-19
Accepted
2018-10-19 16:31:00
Documents
1
Period of Report
2018-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 tv505108_form3.html 3  
1 FORM 3 tv505108_form3.xml 3 2477
  Complete submission text file 0001144204-18-054561.txt   3868
Mailing Address C/O LFB 3, AVENUE DES TROPIQUES, LES ULIS COURTABOEUF I0 91940
Business Address
Bechon Christian (Reporting) CIK: 0001384030 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38128 | Film No.: 181130739

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations